6 views
# A Patient with cardiovascular disease # --- [![](https://cardio-balance-ph.store-best.net/img/7.jpg)](https://cardio-balance-ph.store-best.net) <div style="height:500px;"></div> ## A Patient with cardiovascular disease ## Minsan, dinadagdagan ng doktor ang base na therapy (mga gamot na kailangang inumin araw-araw) ng mga gamot na iniinom kapag may krisis, kapag ang presyon ay sobrang taas at biglang tumaas. At ang dosis ay pinipili rin nang napaka-indibidwal. Kaya imposible na sabihin kung alin ang pinakamahusay na gamot sa presyon, sa bawat kaso ay magkakaroon ng sariling kombinasyon na bagay sa iyo. A Patient with cardiovascular disease: a case description and treatment approach Introduction Cardiovascular diseases represent one of the leading causes of death worldwide and associated with significant health and socio-economic consequences. In the Following, the disease course of a patient is presented with multiple cardiovascular risk factors and diagnosed cardiovascular disease. Case description The Patient, Mr M., 62 years old, presented himself at the emergency room because of persistent chest pain and shortness of breath. A history of in addition, the following risk factors have been identified: Hypertension (for 10 years, irregular use of medication); Hyperlipidemia (elevated levels of LDL‑cholesterol values); Diabetes mellitus type 2 (for 8 years); Nicotine (20 cigarettes per day for 35 years); family history (father died at the age of 58 in a myocardial infarction). Clinical examination and diagnosis The physical examination revealed: Blood pressure: 165/100 mmHg; Heart Rate: 92 PERC a ge/min; slight Oedema of the legs; distorted heart sounds. Further diagnostic measures included: Electrocardiogram (ECG) Shows ST‑Segment depression, indicating myocardial ischemia. Echocardiography: a Reduced left ventricular ejection fraction (40%), regional wall motion abnormalities. Laboratory parameters: Increased Troponin values, LDL cholesterol 4.2 mmol/l. Coronary angiography: stenosis of the left anterior descending artery by 75%. Based on these findings, the diagnosis of coronary heart disease (CHD) was completed, followed by stable Angina pectoris and cardiogenic heart failure. Therapeutic Approach The multi-modal treatment plan consisted of: Drug Therapy: ACE inhibitors (for lowering blood pressure and heart protection); Beta-blockers (used to lower the heart rate and oxygen demand); Statins (for lipid-lowering); Acetylsalicylic acid (for the inhibition of platelet aggregation); Diuretics (in the case of Edema fluid reduction). Lifestyle changes: Abstinence from Smoking; Change in diet (DASH diet); regular physical activity (30 minutes of moderate aerobic exercise, 5 days per week); Weight control. Interventional Treatment: Percutaneous coronary Intervention (PCI) with stent implantation for revascularization of the affected artery. Forecast and long-term management After the implementation of the PCI and the establishment of the drug, as well as lifestyle-related measures, a significant improvement in the symptoms showed up. Regular follow-up examinations, blood pressure control, and laboratory monitoring (lipids, renal function) are for the optimization of the prognosis is essential. Training for self-management ability and psycho-social support contribute to Compliance. Conclusion This case illustrates diseases, the complexity of the diagnosis and therapy of cardiovascular disease. An interdisciplinary approach combining pharmacological, interventional and preventive measures for the treatment of patients with multi-factorial risks of Central importance. Kasabay nito, hindi inirerekomenda ang pangmatagalang pag-inom ng mga gamot mula sa kategoryang Diuretics, dahil ang mahahalagang sangkap tulad ng Potassium, Calcium, Magnesium ay mabilis na nailalabas sa katawan kasama ng sobrang tubig at asin. Alinsunod sa katangiang ito, sinasabayan ng mga Diuretics ang pag-inom ng mga gamot na may laman ng mga sangkap na ito. Maaaring ito ay mga vitamin at mineral na complexes, monokomponent, o mga suplemento sa pagkain na may napatunayang klinikal na bisa. > If you have disturbed sleep, fatigue, disorientation, confusion, or nervousness, it's time to monitor your blood pressure. Either lack of sleep or too much sleeping might mean your blood pressure is high or low. If it’s left untreated, you will soon face an onslaught of multiple illnesses. ![](https://cardio-balance-ph.store-best.net/img/9.jpg) <a href="https://md.mandragot.org/s/zfH_iYcZPS">https://md.mandragot.org/s/zfH_iYcZPS</a> Kung nagsimula na ang pag-inom ng gamot para sa mataas na presyon, hindi ibig sabihin na hindi na maaaring gawin ang karagdagang mga hakbang para palakasin ang katawan sa programa ng therapy. Ang benepisyo ng maingat na mga hakbang na pinagkasunduan ng doktor ay nakakatulong para mapigilan ang paglala ng sakit at maiwasang lumipat ito sa mas seryosong yugto. <a href="https://pad.sra.uni-hannover.de/s/tJDrg1jlHO">MAGBASA PA</a> A Patient with cardiovascular disease: a case description and treatment approach Introduction Cardiovascular diseases represent one of the leading causes of death worldwide and associated with significant health and socio-economic consequences. In the Following, the disease course of a patient is presented with multiple cardiovascular risk factors and diagnosed cardiovascular disease. Case description The Patient, Mr M., 62 years old, presented himself at the emergency room because of persistent chest pain and shortness of breath. A history of in addition, the following risk factors have been identified: Hypertension (for 10 years, irregular use of medication); Hyperlipidemia (elevated levels of LDL‑cholesterol values); Diabetes mellitus type 2 (for 8 years); Nicotine (20 cigarettes per day for 35 years); family history (father died at the age of 58 in a myocardial infarction). Clinical examination and diagnosis The physical examination revealed: Blood pressure: 165/100 mmHg; Heart Rate: 92 PERC a ge/min; slight Oedema of the legs; distorted heart sounds. Further diagnostic measures included: Electrocardiogram (ECG) Shows ST‑Segment depression, indicating myocardial ischemia. Echocardiography: a Reduced left ventricular ejection fraction (40%), regional wall motion abnormalities. Laboratory parameters: Increased Troponin values, LDL cholesterol 4.2 mmol/l. Coronary angiography: stenosis of the left anterior descending artery by 75%. Based on these findings, the diagnosis of coronary heart disease (CHD) was completed, followed by stable Angina pectoris and cardiogenic heart failure. Therapeutic Approach The multi-modal treatment plan consisted of: Drug Therapy: ACE inhibitors (for lowering blood pressure and heart protection); Beta-blockers (used to lower the heart rate and oxygen demand); Statins (for lipid-lowering); Acetylsalicylic acid (for the inhibition of platelet aggregation); Diuretics (in the case of Edema fluid reduction). Lifestyle changes: Abstinence from Smoking; Change in diet (DASH diet); regular physical activity (30 minutes of moderate aerobic exercise, 5 days per week); Weight control. Interventional Treatment: Percutaneous coronary Intervention (PCI) with stent implantation for revascularization of the affected artery. Forecast and long-term management After the implementation of the PCI and the establishment of the drug, as well as lifestyle-related measures, a significant improvement in the symptoms showed up. Regular follow-up examinations, blood pressure control, and laboratory monitoring (lipids, renal function) are for the optimization of the prognosis is essential. Training for self-management ability and psycho-social support contribute to Compliance. Conclusion This case illustrates diseases, the complexity of the diagnosis and therapy of cardiovascular disease. An interdisciplinary approach combining pharmacological, interventional and preventive measures for the treatment of patients with multi-factorial risks of Central importance. ## Pregnancy and diseases of the circulatory System ## Pregnancy and diseases of the cardiovascular system Pregnancy represents a significant physiological challenge for the cardiovascular System of a woman. During this Phase, the cardiovascular parameters undergone significant changes, which allow for an adaptation to the increased requirements of the maternal and fetal organism. Physiological changes during pregnancy In the course of the pregnancy, the blood volume by 30-50%, which leads to increased heart rate and increased Cardiac output increases. The systolic and diastolic function of the heart remains generally stable, however, the systemic vascular resistance decreases due to the vasodilatory effect of hormones such as progesterone. These changes lead to a slight reduction in blood pressure in the middle of the pregnancy, before he rises again towards the end. Common cardiovascular diseases in Pregnant women Existing or new onset of cardiovascular disease may increase the risk for the mother and the child considerably. Among the most common diseases: Pre-eclampsia is a hypertensive disorder, which is characterized by increased blood pressure and often proteinuria. It typically occurs after 20. Week of pregnancy and can lead to life-threatening complications. Gestational diabetes — although primarily a metabolic disorder, it disorders the risk for subsequent cardiovascular, and can cause during pregnancy high blood pressure. Valvular insufficiencies, particularly mitral stenosis and aortic stenosis, which may be due to the increased cardiac load is symptomatic. Arrhythmias, including atrial fibrillation and supraventricular tachycardia, which can occur during pregnancy or deteriorate. Peripartale cardiomyopathy — a rare but serious illness that can be developed in the last months of Pregnancy or in the first few months after birth and lead to heart failure. Diagnostics and Monitoring The accurate diagnosis of cardiovascular diseases in pregnant women requires a multi-disciplinary approach. Among the common methods of investigation: Blood pressure measurement; ECG; Echocardiography; Laboratory tests (including kidney and liver function tests, electrolytes); Monitoring of fetal well-being (Doppler ultrasonography). Therapeutic Strategies The treatment depends on the specific disease and the severity. Important aspects are: Blood pressure control: in pre-eclampsia or chronic hypertension are used antihypertensive drugs such as Methyldopa, Labetalol or nifedipine. Medication management: careful consideration of the risks and Benefits of medicines, because many cardiovascular drugs can be potentially teratogenic. Regular Monitoring: close collaboration between gynecologists, cardiologists and neonatologists to optimize the supply. Style changes: a healthy diet, moderate physical activity and stress reduction life. Conclusion A close interdisciplinary care is essential to reduce the risk of complications in pregnant women with cardiovascular minimize disease. Early diagnosis, individual therapy concepts, and regular Monitoring will enable it to protect both the health of the mother as well as the development of the fetus optimally. Would you like me to make a certain section in greater detail or further information to a themed area to add? <a href="https://hedgedoc.ichmann.de/s/ql7cvUHumU">The last blood pressure pills</a> A Patient with cardiovascular disease. <a href="https://doc.interscalar.eu/s/GiD5oSBLk">A Patient with cardiovascular disease</a> <a href="https://doc.gnuragist.es/s/pnIy2y0-rW">Pregnancy and diseases of the circulatory System</a> <a href="https://hd.wedler.me/s/mLm6HX2vB">The last blood pressure pills</a> <a href="https://md.chaosdorf.de/s/DQ_NU1FbyT">https://md.chaosdorf.de/s/DQ_NU1FbyT</a> <a href="https://md.sigma2.no/s/Y2nVtYVmS">https://md.sigma2.no/s/Y2nVtYVmS</a> <a href="https://hd.wedler.me/s/6bKnVOBKb">https://hd.wedler.me/s/6bKnVOBKb</a> <a href="https://doc.cisti.org/s/N-HtKUc6i7">https://doc.cisti.org/s/N-HtKUc6i7</a> <a href="https://pad.gusted.xyz/s/5CxRIjW4E">https://pad.gusted.xyz/s/5CxRIjW4E</a> <a href="https://notas.gaiacoop.tech/s/quGOAGWda">https://notas.gaiacoop.tech/s/quGOAGWda</a> <a href="https://doc.spiegie.de/s/E_U7gicKa">https://doc.spiegie.de/s/E_U7gicKa</a> <a href="https://pads.dgnum.eu/s/wZzUt-u-VU">https://pads.dgnum.eu/s/wZzUt-u-VU</a> <a href="https://pads.cantorgymnasium.de/s/0uAt74LHd">https://pads.cantorgymnasium.de/s/0uAt74LHd</a> <a href="https://write.frame.gargantext.org/s/B1eMl9lXze">https://write.frame.gargantext.org/s/B1eMl9lXze</a> <a href="https://notes.simeonreusch.com/s/B2ACZxwo1">https://notes.simeonreusch.com/s/B2ACZxwo1</a> <a href="https://md.mandragot.org/s/X14y0t51u7">https://md.mandragot.org/s/X14y0t51u7</a> <a href="https://hedgedoc.digilol.net/s/nKff8Wqeju">https://hedgedoc.digilol.net/s/nKff8Wqeju</a> <a href="https://hedgedoc.private.coffee/s/g25TRwFnX">https://hedgedoc.private.coffee/s/g25TRwFnX</a> <a href="https://pad.cttue.de/s/5tIFFcHhA">https://pad.cttue.de/s/5tIFFcHhA</a> <a href="https://pad.medialepfade.net/s/KWX96qtXk">https://pad.medialepfade.net/s/KWX96qtXk</a> <a href="https://hdoc.csirt-tooling.org/s/sCdo7h9rqH">https://hdoc.csirt-tooling.org/s/sCdo7h9rqH</a> <a href="https://notes.rabjerg.de/s/HyGFM5lmMe">https://notes.rabjerg.de/s/HyGFM5lmMe</a> <a href="https://dok.kompot.si/s/lwneQtM3i7">https://dok.kompot.si/s/lwneQtM3i7</a> <a href="https://pad.dominick-leppich.de/s/Y7UigXSfN">https://pad.dominick-leppich.de/s/Y7UigXSfN</a> <a href="https://hedgedoc.auro.re/s/uB3zPqSXNg">https://hedgedoc.auro.re/s/uB3zPqSXNg</a> <a href="https://hedgedoc.nrp-nautilus.io/s/OiglsG16AP">https://hedgedoc.nrp-nautilus.io/s/OiglsG16AP</a> <a href="https://md.rappet.xyz/s/lzz80rupcu">https://md.rappet.xyz/s/lzz80rupcu</a> <a href="https://md.eris.cc/s/WytriDtF7B">https://md.eris.cc/s/WytriDtF7B</a> <a href="https://hedgedoc.obermui.de/s/SJ7AimjlXy">https://hedgedoc.obermui.de/s/SJ7AimjlXy</a> <a href="https://hack.utopia-lab.org/s/RgX9_ZpUN">https://hack.utopia-lab.org/s/RgX9_ZpUN</a> <a href="https://hedgedoc.et.aksw.org/s/AdXeCrURs">https://hedgedoc.et.aksw.org/s/AdXeCrURs</a> <a href="https://hackmd.openmole.org/s/4uRm1ZmTD">https://hackmd.openmole.org/s/4uRm1ZmTD</a> <a href="https://hackmd.k15.synology.me/s/3xwGfaWJX">https://hackmd.k15.synology.me/s/3xwGfaWJX</a> <a href="https://md.gafert.org/s/WWCvGjghV">https://md.gafert.org/s/WWCvGjghV</a> <a href="https://hedgedoc.team23.org/s/x6yE1c87DL">https://hedgedoc.team23.org/s/x6yE1c87DL</a> <a href="https://doc.neutrinet.be/s/PwggPBFnnY">https://doc.neutrinet.be/s/PwggPBFnnY</a> <a href="https://hedge.grin.hu/s/jLFSdS8de0">https://hedge.grin.hu/s/jLFSdS8de0</a> <a href="https://docs.localcharts.org/s/K_D3oErsM">https://docs.localcharts.org/s/K_D3oErsM</a> <a href="https://doc.fung.uy/s/7py6eIxL1F">https://doc.fung.uy/s/7py6eIxL1F</a> <a href="https://md.softwarefreedom.net/s/gzruQjqSs">https://md.softwarefreedom.net/s/gzruQjqSs</a> <a href="https://n.jo-so.de/s/UlVmFLKNr">https://n.jo-so.de/s/UlVmFLKNr</a> <a href="https://pad.medialepfade.net/s/O53CdfydK">https://pad.medialepfade.net/s/O53CdfydK</a> <a href="https://md.micronited.de/s/B13pMqeQMg">https://md.micronited.de/s/B13pMqeQMg</a> ## The last blood pressure pills ## The last pills for high blood pressure: New developments in the pharmacotherapy High blood pressure, known medically as hypertension, is one of the most common chronic diseases worldwide and is considered to be the main cause for cardiovascular diseases, strokes, and kidney damage. The WHO estimates that over a billion people suffer from hypertension, which is why the development of effective therapies is of high relevance. State-of-the conventional therapy The current guidelines (e.g., the European Society of Cardiology, ESC) recommend as a first‑line therapy, a combination of different classes of Drugs: ACE inhibitors (eg, Lisinopril) — block the Angiotensin‑converting enzymes, thereby lowering the blood pressure; AT1‑Receptor antagonists (known as Sartans, e.g., Losartan) — inhibit the action of Angiotensin II; Calcium channel blockers (e.g. amlodipine) — lead vessels to a relaxation of the blood; Diuretics (such as hydrochlorothiazide) to promote the excretion of water and salt; Beta-blockers (e.g., Metoprolol) — decrease of ejection and the heart rate and the Heart. Despite these many options, the patient's blood pressure remains at about 30%, despite multiple medication is not adequately controlled (resistant hypertension). This motivates the search for new drugs and therapeutic approaches. The latest developments and innovative pills In recent years, several novel agents have been developed that operate on different biochemical levels: Endothelin Receptor Antagonists (ERAs) Substances such as Atrasentan inhibit the vasoconstrictor effect of Endothelin‑1 and a significant blood show in studies pressure reduction, especially in patients with chronic kidney disease. Renin Inhibitors Aliskiren was the first direct Renin Inhibitor, however, with limited application because of possible side effects. Current analogues with improved safety profiles are currently being tested in clinical trials. Neprilysin inhibitors in combination with Sartans The fixed combination of Sacubitril (a Neprilysin inhibitor) and Valsartan (an AT1 Receptor Antagonist), is already approved for the treatment of congestive heart failure and hypertension good results. Antisense oligonucleotides against Angiotensinogen This innovative strategy aims to block the synthesis of Angiotensinogen in the liver. In early studies, it was shown a long — lasting blood pressure control after only one injection, a potential breakthrough for patients with poor medication adherence. Dual‑Active Compounds (Single‑Pill Combinations) New formulations combine two or even three active ingredients in one tablet (for example, amlodipine + Valsartan + hydrochlorothiazide), what is the therapy increases easier and the patient's adherence. Challenges and perspectives Although these new therapies are promising, there remain challenges: Long‑term safety and side effect profiles need to be further investigated; the cost of such innovative drugs are often high; individual therapy adjustment remains essential, not every new pill is suitable for each patient. In summary, we can say that the pharmacotherapy of hypertension has evolved. The latest pills and strategies, particularly for patients with resistant hypertension, a new hope. At the same time, the combination of drugs, remains a style change, and regular measurement of blood pressure life is the Foundation of a successful long-term therapy.